Integration of Transcriptomics, Proteomics and Loss-of-Function Screening Reveals Wee1 as a Target for Combination with Dasatinib Against Proneural Glioblastoma

Obada Alhalabi, Mona Göttmann, Maxwell P. Gold, Silja Schlue, Thomas Hielscher, Murat Iskar, Tobias Keßler, Ling Hai, Tolga Lokumcu, Clara C. Cousins, Christel Herold‐Mende, Bernd Heßling, Sandra Horschitz, Ammar Jabali, Philipp Koch, Ulrich Baumgartner, Bryan W. Day, Wolfgang Wick, Felix Sahm, Sandro M. Krieg, Ernest Fraenkel, Emma Phillips, Violaine Goidts

BibTeX
@inproceedings{alhalabi2024integration,
  author = {Obada Alhalabi and Mona Göttmann and Maxwell P. Gold and Silja Schlue and Thomas Hielscher and Murat Iskar and Tobias Keßler and Ling Hai and Tolga Lokumcu and Clara C. Cousins and Christel Herold‐Mende and Bernd Heßling and Sandra Horschitz and Ammar Jabali and Philipp Koch and Ulrich Baumgartner and Bryan W. Day and Wolfgang Wick and Felix Sahm and Sandro M. Krieg and Ernest Fraenkel and Emma Phillips and Violaine Goidts},
  title = {{Integration of Transcriptomics, Proteomics and Loss-of-Function Screening Reveals Wee1 as a Target for Combination with Dasatinib Against Proneural Glioblastoma}},
  booktitle = {Cancer},
  year = {2024},
  doi = {10.1016/j.canlet.2024.217265},
}

Loading related content...

Figure